Activity ID
14066Expires
June 30, 2027Format Type
LiveCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
Engage with experts from around the world as they discuss the latest advances in the diagnosis and treatment of a range of psychiatric illnesses, debate controversies in the field, and share their clinical pearls. Earn up to 5 hours of CME/CE credit.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
YesNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
• Define the distinctive mechanisms of action and pharmacokinetic characteristics of novel and emerging therapeutic agents for schizophrenia that extend beyond traditional antidopaminergic approaches
• Assess efficacy and safety data, adverse events of novel and emerging treatments for schizophrenia
• Explain the clinical utility of novel antipsychotics to address unmet needs of current schizophrenia treatments
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Inpatient, Outpatient, Rural, Urban, VA/Military
